Should All Atrial Fibrillation Be Considered a Life-Long Problem Requiring Prophylaxis Against Thromboembolism?

J Am Coll Cardiol. 2018 Oct 23;72(17):2037-2039. doi: 10.1016/j.jacc.2018.07.087.

Authors

Anne B Curtis¹, Hassan A Khan²

Affiliations

¹ Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York. Electronic address: abcurtis@buffalo.edu.
² Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York.

PMID: 30336827
DOI: 10.1016/j.jacc.2018.07.087

No abstract available

Keywords: atrial fibrillation; epidemiology; surgery; thromboembolism.

Publication types

Editorial
Comment

MeSH terms

Atrial Fibrillation*
Humans
Thromboembolism*
Warfarin

Substances

Warfarin